Bioengineering is a discipline that advances knowledge in engineering, biology and medicine, and improves human health through cross-disciplinary activities that integrate the engineering sciences with the biomedical sciences and clinical practice. It includes: (1) the acquisition of new knowledge and understanding of living systems through the innovative and substantive application of experimental and analytical techniques based on the engineering sciences, and (2) the development of new devices, algorithms, processes and systems that advance biology and medicine and improve medical practice and health care delivery. Inframat Corporation is developing hydroxyapatite ("HA") nanocoatings for implantable artificial bones, and is in the process of developing two types of nanostructured biosensors, including nanoparticle based glucose sensors for diabetes application, and bioconjugated nanoparticle based biosensors for neurotransmitter detection applications.